Cargando…
Progress and application of circulating tumor cells in non-small cell lung cancer
Non-small cell lung cancer (NSCLC) has the highest morbidity and mortality worldwide among malignant tumors. NSCLC is a great threat to health and well-being. Biopsy is the gold standard to diagnose lung cancer, but traditional biopsy methods cannot fully reflect the true condition of tumors. There...
Autores principales: | Qian, Huizhu, Zhang, Yue, Xu, Jing, He, Jing, Gao, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408556/ https://www.ncbi.nlm.nih.gov/pubmed/34514090 http://dx.doi.org/10.1016/j.omto.2021.05.005 |
Ejemplares similares
-
Circulating tumor cell methylation profiles reveal the classification and evolution of non-small cell lung cancer
por: Jiang, Jia-Hao, et al.
Publicado: (2022) -
Prognostic significance of circulating tumor cells in non-small cell lung cancer patients undergoing chemotherapy
por: Tong, Bing, et al.
Publicado: (2017) -
Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer
por: Xin, Liu, et al.
Publicado: (2023) -
Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
por: Yang, Jialiang, et al.
Publicado: (2021) -
Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015)